• Neutral Trial, Positive Spin: PROTECTED TAVR

    3 days ago - By Medscape

    The primary endpoint was negative for a trial of embolic protection during transcatheter aortic valve replacement, yet the paper's conclusion emphasized the potential benefit.
    theheart.org on Medscape
    Read more ...

     

  • VIDEO: Wilson discusses PROTECTED TAVR, CLASP IID trials and more from TCT 2022

    VIDEO: Wilson discusses PROTECTED TAVR, CLASP IID trials and more from TCT 2022

    3 days ago - By Healio

    BOSTON - In this Healio video exclusive, B. Hadley Wilson, MD, FACC, discussed late-breaking research in transcatheter aortic valve replacement, and more presented at TCT 2022.
    Wilson, who is executive vice chair of Atrium Health's Sanger Heart and Vascular Institute and clinical professor of medicine at UNC School of Medicine, provided his perspective on the PROTECTED TAVR and CLASP IID trials as well as findings from analyses of the TVT and U.K. National Registries.
    Watch the video for more.
    Read more ...